Wedbush Initiates Coverage On Korsana Biosciences with Outperform Rating, Announces Price Target of $44
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsInitiationPrice Target
Wedbush analyst Laura Chico initiates coverage on Korsana Biosciences (NASDAQ:KRSA) with a Outperform rating and announces Price Target of $44.
Wedbush analyst Laura Chico initiates coverage on Korsana Biosciences (NASDAQ:KRSA) with a Outperform rating and announces Price Target of $44.